Animal Ocular Toxicity Studies Through Ocular Delivery
Introduction The ocular drug development landscape is rapidly expanding, encompassing small molecules, biologics, gene and cell therapies, and novel drug delivery platforms. Increasingly, ocular delivery routes such as intravitreal, subconjunctival, and periocular administration are being used to target the posterior segment of the eye and support the development of injectable and implantable prolonged-action dosage forms….